*Completing the assessment on the Harper Meds website does not establish a doctor-patient relationship between the individual and Harper Meds. Wasef Health and Beluga Health, networks of US-licensed physicians committed to rigorous medical protocols to ensure patient safety, have established exclusionary criteria to determine whether an individual is ineligible for weight loss prescriptions. The responses provided in the Harper Meds assessment will determine if an individual is considered excluded or non-excluded. Harper Meds serves as a facilitator, connecting non-excluded individuals with these networks and their clinicians. The decision to prescribe weight loss medications lies solely with Wasef Health and Beluga Health clinicians, thereby forming the doctor-patient relationship with those seeking a prescription.

Results from the compounded medications available through the Harper Meds platform may vary. These compounded medications, including Semaglutide and Tirzepatide, are manufactured in FDA-licensed 503A Outsourcing Facilities. Although these facilities are subject to stringent regulation, the medications themselves are not FDA-approved, as they are tailored to individual prescriptions for specific patients. The decision to use compounded medications is based on the licensed provider’s medical judgment, informed by a telehealth consultation and the patient’s medical history.

We advise all potential users of compounded Semaglutide and compounded Tirzepatide to discuss the particular risks and benefits of compounded medications with their healthcare provider. As Harper Meds is not involved in the production of these medications, the medication you receive may differ in appearance from what is depicted on the website.*